🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

When Jacqueline, 68, needed CAR-T therapy, she had to travel 400+ miles from Las Vegas to Salt Lake City. Now, that same treatment is available at Intermountain Health's St. George Cancer Center — bringing life-saving care closer to home. 🔗 ksl.com/article/513144…

We've partnered with MaxCyte, Inc. to increase manufacturing efficiencies and patient access. By integrating ExPERT™ with IRO®, we’ve improved T cell yields and shortened timelines – a step forward in scalable autologous cell therapy manufacturing. 🔗 oribiotech.com/press-releases…

🧬 @ Cardinal Health has released its 2025 Advanced Therapies Report, highlighting what's required to deliver cell and gene therapies at scale, without leaving patients behind. We’ve summarised the key takeaways ⬇️ Read the full report: cardinalhealth.com/content/dam/co…

🧬Delivering CAR-T therapy in the community is key for increasing #PatientAccess At #COA2025, Dr. Nini Wu highlighted the barriers that clinics face: staffing, delivery costs & operational complexity. 🔗 ajmc.com/view/oncology-…

Heading to Biotechnology Innovation Organization 2025? Don’t miss Jason C. Foster as he joins a panel of CGT leaders to discuss how to scale CGT. 📆06.16 | 15:00–16:00 ET 📍Room 206AB 💬How to Best Scale CGT Manufacturing: Bringing Together Disparate Approaches convention.bio.org/program-1/best…

How can automation strategies reduce manufacturing costs and improve patient access? Jason C. Foster speaks with Dr. Julie Allickson of Mayo Clinic about how academic centers are scaling up, with automation and real-world delivery in mind. 🎧Listen now: oribiotech.com/podcasts/ori-s…

After the U.S. FDA's CGT roundtable, senior leaders have acknowledged what many already know. We won’t see widespread #PatientAccess without regulatory systems that support manufacturability and commercial viability from the start. linkedin.com/feed/update/ur…

In 2016, firefighter Nick Howe was diagnosed with aggressive lymphoma. When other treatments failed, he joined a CAR-T trial at Nebraska Medicine. He was in remission within weeks. Now, he’s giving back, raising funds for research & patient care. 🔗 youtube.com/watch?app=desk…

Scientific momentum in CGTs is high, but we’re yet to see impact at scale. At Alliance for Regenerative Medicine (ARM) Cell and Gene Therapy Catapult's Workshop, Jason C. Foster joined the ‘Robots, Automation, and AI/ML’ panel to explore how tech can help the industry design for scale and deliver on CGT's commercial potential.

🎙️ Our CEO Jason C. Foster is taking to the stage for SomX's Healthtech Talks with Google Cloud, where he'll join a panel exploring the role of #tech in enabling patient impact at scale. 📆 June 30, 18:30 BST 📍London Register your interest: docs.google.com/forms/d/e/1FAI…

Developers need #Manufacturing solutions that evolve with the science, support rapid iteration & scale across therapy portfolios. That’s why we built IRO® – a flexible, modular platform to support development from R&D through to GMP. Read our Whitepaper➡️…822682.fs1.hubspotusercontent-na1.net/hubfs/46822682…